ARTICLE | Clinical News
Bryostatin-1 regulatory update
April 20, 2015 7:00 AM UTC
Neurotrope said FDA granted Orphan Drug designation to bryostatin-1 to treat Fragile X syndrome. The protein kinase C (PKC) epsilon (PKCE) activator has completed a Phase IIa trial to treat Alzheimer...